Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
33
AGCO Quote, Financials, Valuation and Earnings
Last price:
$93.10
Seasonality move
:
6.02%
Day range:
$91.91 - $93.84
52-week range:
$84.35 - $125.76
Dividend yield:
1.25%
P/E ratio:
43.40x
P/S ratio:
0.60x
P/B ratio:
1.86x
Volume:
2.8M
Avg. volume:
954.9K
1-year change:
-21.13%
Market cap:
$6.9B
Revenue:
$11.7B
EPS (TTM):
-$5.69
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.1B | $11.1B | $12.7B | $14.4B | $11.7B | |
| Revenue Growth (YoY) | 1.2% | 21.73% | 13.59% | 13.92% | -19.08% | |
| Cost of Revenues | $7.1B | $8.6B | $9.7B | $10.6B | $8.8B | |
| Gross Profit | $2.1B | $2.6B | $3B | $3.8B | $2.9B | |
| Gross Profit Margin | 22.49% | 23.09% | 23.72% | 26.21% | 24.86% | |
| R&D Expenses | $342.6M | $405.8M | $444.2M | $548.8M | $493M | |
| Selling, General & Admin | $1B | $1.1B | $1.2B | $1.5B | $1.4B | |
| Other Inc / (Exp) | -$76.9M | -$65.7M | -$187.3M | -$378.3M | -$1.3B | |
| Operating Expenses | $1.4B | $1.6B | $1.7B | $2.1B | $2B | |
| Operating Income | $653.9M | $1B | $1.3B | $1.7B | $927.4M | |
| Net Interest Expenses | $15M | $6.7M | $13M | $4.6M | $93M | |
| EBT. Incl. Unusual Items | $562M | $944.3M | $1.1B | $1.3B | -$433.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $187.7M | $108.4M | $296.6M | $230.4M | $98.4M | |
| Net Income to Company | $419.8M | $901.5M | $874.7M | $1.2B | -$485.6M | |
| Minority Interest in Earnings | $7.3M | -$4.5M | $14.9M | $100K | $60.8M | |
| Net Income to Common Excl Extra Items | $427.1M | $897M | $889.6M | $1.2B | -$424.8M | |
| Basic EPS (Cont. Ops) | $5.69 | $11.93 | $11.92 | $15.66 | -$5.69 | |
| Diluted EPS (Cont. Ops) | $5.65 | $11.85 | $11.87 | $15.63 | -$5.69 | |
| Weighted Average Basic Share | $75M | $75.2M | $74.6M | $74.8M | $74.6M | |
| Weighted Average Diluted Share | $75.6M | $75.7M | $74.9M | $74.9M | $74.7M | |
| EBITDA | $858.9M | $1.3B | $1.4B | $1.7B | $57.9M | |
| EBIT | $586.9M | $969.7M | $1.2B | $1.4B | -$274.3M | |
| Revenue (Reported) | $9.1B | $11.1B | $12.7B | $14.4B | $11.7B | |
| Operating Income (Reported) | $653.9M | $1B | $1.3B | $1.7B | $927.4M | |
| Operating Income (Adjusted) | $586.9M | $969.7M | $1.2B | $1.4B | -$274.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.2B | $3.9B | $3.8B | $2.9B | |
| Revenue Growth (YoY) | 8.1% | 16.12% | 23.57% | -2.52% | -24.03% | |
| Cost of Revenues | $2.1B | $2.5B | $3B | $2.8B | $2.2B | |
| Gross Profit | $595.6M | $682.7M | $940.6M | $982.8M | $688.7M | |
| Gross Profit Margin | 21.92% | 21.64% | 24.13% | 25.86% | 23.85% | |
| R&D Expenses | $99.9M | $109.5M | $132.1M | $150.8M | $103M | |
| Selling, General & Admin | $283.1M | $285.7M | $328.4M | $416.8M | $323.2M | |
| Other Inc / (Exp) | -$4.7M | -$18.4M | -$72.5M | -$157.4M | -$554.8M | |
| Operating Expenses | $397.8M | $410.5M | $475.2M | $582M | $452.8M | |
| Operating Income | $197.8M | $272.2M | $465.4M | $400.8M | $235.9M | |
| Net Interest Expenses | $1.9M | -- | $4.4M | -- | $27.3M | |
| EBT. Incl. Unusual Items | $191.2M | $253.9M | $388.5M | $250.6M | -$346.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $69.8M | -$13M | $90.7M | -$76.1M | -$24.2M | |
| Net Income to Company | $135.4M | $283.3M | $322.2M | $339M | -$313.6M | |
| Minority Interest in Earnings | -- | -$1.2M | -- | -- | $57.9M | |
| Net Income to Common Excl Extra Items | $135.4M | $282.1M | $322.2M | $339M | -$255.7M | |
| Basic EPS (Cont. Ops) | $1.81 | $3.77 | $4.32 | $4.54 | -$3.42 | |
| Diluted EPS (Cont. Ops) | $1.78 | $3.75 | $4.29 | $4.53 | -$3.42 | |
| Weighted Average Basic Share | $75M | $74.9M | $74.6M | $74.5M | $74.6M | |
| Weighted Average Diluted Share | $75.9M | $75.4M | $74.9M | $74.6M | $74.7M | |
| EBITDA | $275.4M | $344.3M | $493M | $383.5M | -$164.2M | |
| EBIT | $203M | $272.5M | $425.9M | $307.6M | -$252.6M | |
| Revenue (Reported) | $2.7B | $3.2B | $3.9B | $3.8B | $2.9B | |
| Operating Income (Reported) | $197.8M | $272.2M | $465.4M | $400.8M | $235.9M | |
| Operating Income (Adjusted) | $203M | $272.5M | $425.9M | $307.6M | -$252.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.1B | $11.1B | $12.7B | $14.4B | $11.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.1B | $8.6B | $9.7B | $10.6B | $8.8B | |
| Gross Profit | $2.1B | $2.6B | $3B | $3.8B | $2.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $342.6M | $405.8M | $444.2M | $548.8M | $493M | |
| Selling, General & Admin | $1B | $1.1B | $1.2B | $1.5B | $1.4B | |
| Other Inc / (Exp) | -$76.9M | -$65.7M | -$187.3M | -$378.3M | -$1.3B | |
| Operating Expenses | $1.4B | $1.6B | $1.7B | $2.1B | $2B | |
| Operating Income | $653.9M | $1B | $1.3B | $1.7B | $927.4M | |
| Net Interest Expenses | $15M | $6.7M | $13M | $4.6M | $93M | |
| EBT. Incl. Unusual Items | $562M | $944.3M | $1.1B | $1.3B | -$433.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $187.7M | $108.4M | $296.6M | $230.4M | $98.4M | |
| Net Income to Company | $419.8M | $901.5M | $874.7M | $1.2B | -$485.6M | |
| Minority Interest in Earnings | $7.3M | -$4.5M | $14.9M | $100K | $60.8M | |
| Net Income to Common Excl Extra Items | $427.1M | $897M | $889.6M | $1.2B | -$424.8M | |
| Basic EPS (Cont. Ops) | $5.70 | $11.92 | $11.92 | $15.66 | -$5.69 | |
| Diluted EPS (Cont. Ops) | $5.65 | $11.87 | $11.87 | $15.63 | -$5.69 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $858.9M | $1.3B | $1.4B | $1.7B | $57.9M | |
| EBIT | $586.9M | $969.7M | $1.2B | $1.4B | -$274.3M | |
| Revenue (Reported) | $9.1B | $11.1B | $12.7B | $14.4B | $11.7B | |
| Operating Income (Reported) | $653.9M | $1B | $1.3B | $1.7B | $927.4M | |
| Operating Income (Adjusted) | $586.9M | $969.7M | $1.2B | $1.4B | -$274.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.1B | $12.7B | $14.4B | $11.7B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.6B | $9.7B | $10.6B | $8.8B | -- | |
| Gross Profit | $2.6B | $3B | $3.8B | $2.9B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $405.8M | $444.2M | $548.8M | $493M | -- | |
| Selling, General & Admin | $1.1B | $1.2B | $1.5B | $1.4B | -- | |
| Other Inc / (Exp) | -$65.7M | -$187.3M | -$378.3M | -$1.3B | -- | |
| Operating Expenses | $1.6B | $1.7B | $2.1B | $2B | -- | |
| Operating Income | $1B | $1.3B | $1.7B | $927.4M | -- | |
| Net Interest Expenses | $6.8M | $13M | $11.8M | $93M | -- | |
| EBT. Incl. Unusual Items | $944.3M | $1.1B | $1.3B | -$433.6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $108.4M | $296.6M | $230.4M | $98.4M | -- | |
| Net Income to Company | $901.5M | $874.7M | $1.2B | -$485.6M | -- | |
| Minority Interest in Earnings | -$4.5M | $14.9M | $100K | $60.8M | -- | |
| Net Income to Common Excl Extra Items | $897M | $889.6M | $1.2B | -$424.8M | -- | |
| Basic EPS (Cont. Ops) | $11.92 | $11.92 | $15.66 | -$5.69 | -- | |
| Diluted EPS (Cont. Ops) | $11.87 | $11.87 | $15.63 | -$5.69 | -- | |
| Weighted Average Basic Share | $300.9M | $298.4M | $299.2M | $298.4M | -- | |
| Weighted Average Diluted Share | $302.8M | $299.6M | $299.6M | $298.8M | -- | |
| EBITDA | $1.3B | $1.4B | $1.7B | $57.9M | -- | |
| EBIT | $969.7M | $1.2B | $1.4B | -$274.3M | -- | |
| Revenue (Reported) | $11.1B | $12.7B | $14.4B | $11.7B | -- | |
| Operating Income (Reported) | $1B | $1.3B | $1.7B | $927.4M | -- | |
| Operating Income (Adjusted) | $969.7M | $1.2B | $1.4B | -$274.3M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $882.2M | $787.5M | $595M | $612M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $856M | $991.5M | $1.2B | $1.6B | $1.3B | |
| Inventory | $2B | $2.6B | $3.2B | $3.4B | $2.7B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $418.9M | $539.8M | $538.8M | $699.3M | $526.6M | |
| Total Current Assets | $4.4B | $5B | $5.7B | $6.3B | $5.1B | |
| Property Plant And Equipment | $1.7B | $1.6B | $1.8B | $2.1B | $2B | |
| Long-Term Investments | $442.7M | $413.5M | $436.9M | $512.7M | $519.6M | |
| Goodwill | $1.3B | $1.3B | $1.3B | $1.3B | $1.8B | |
| Other Intangibles | $455.6M | $392.2M | $364.4M | $308.8M | $728.9M | |
| Other Long-Term Assets | $179.8M | $293.3M | $268.7M | $346.8M | $435.2M | |
| Total Assets | $8.5B | $9.2B | $10.1B | $11.4B | $11.2B | |
| Accounts Payable | $855.1M | $1.1B | $1.4B | $1.2B | $813M | |
| Accrued Expenses | $323.4M | $362.4M | $359.5M | $414.3M | $425.3M | |
| Current Portion Of Long-Term Debt | $359.7M | $92.9M | $196M | $15M | $415.2M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $231.3M | $221.2M | $235.4M | $217.5M | $128.2M | |
| Total Current Liabilities | $3.4B | $3.5B | $4.1B | $4.3B | $3.8B | |
| Long-Term Debt | $1.3B | $1.4B | $1.3B | $1.4B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $5.7B | $6.2B | $6.8B | $7.1B | |
| Common Stock | $800K | $700K | $700K | $700K | $700K | |
| Other Common Equity Adj | -$1.8B | -$1.8B | -$1.8B | -$1.7B | -$1.9B | |
| Common Equity | $3B | $3.4B | $3.9B | $4.7B | $3.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $38M | $27.9M | $200K | $100K | $300.1M | |
| Total Equity | $3B | $3.4B | $3.9B | $4.7B | $4B | |
| Total Liabilities and Equity | $8.5B | $9.2B | $10.1B | $11.4B | $11.2B | |
| Cash and Short Terms | $1.1B | $882.2M | $787.5M | $595M | $612M | |
| Total Debt | $1.6B | $1.5B | $1.5B | $1.4B | $2.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $882.2M | $787.5M | $595M | $612M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $856M | $991.5M | $1.2B | $1.6B | $1.3B | |
| Inventory | $2B | $2.6B | $3.2B | $3.4B | $2.7B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $418.9M | $539.8M | $538.8M | $699.3M | $526.6M | |
| Total Current Assets | $4.4B | $5B | $5.7B | $6.3B | $5.1B | |
| Property Plant And Equipment | $1.7B | $1.6B | $1.8B | $2.1B | $2B | |
| Long-Term Investments | $442.7M | $413.5M | $436.9M | $512.7M | $519.6M | |
| Goodwill | $1.3B | $1.3B | $1.3B | $1.3B | $1.8B | |
| Other Intangibles | $455.6M | $392.2M | $364.4M | $308.8M | $728.9M | |
| Other Long-Term Assets | $179.8M | $293.3M | $268.7M | $346.8M | $435.2M | |
| Total Assets | $8.5B | $9.2B | $10.1B | $11.4B | $11.2B | |
| Accounts Payable | $855.1M | $1.1B | $1.4B | $1.2B | $813M | |
| Accrued Expenses | $323.4M | $362.4M | $359.5M | $414.3M | $425.3M | |
| Current Portion Of Long-Term Debt | $359.7M | $92.9M | $196M | $15M | $415.2M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $231.3M | $221.2M | $235.4M | $217.5M | $128.2M | |
| Total Current Liabilities | $3.4B | $3.5B | $4.1B | $4.3B | $3.8B | |
| Long-Term Debt | $1.3B | $1.4B | $1.3B | $1.4B | $2.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $5.7B | $6.2B | $6.8B | $7.1B | |
| Common Stock | $800K | $700K | $700K | $700K | $700K | |
| Other Common Equity Adj | -$1.8B | -$1.8B | -$1.8B | -$1.7B | -$1.9B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $38M | $27.9M | $200K | $100K | $300.1M | |
| Total Equity | $3B | $3.4B | $3.9B | $4.7B | $4B | |
| Total Liabilities and Equity | $8.5B | $9.2B | $10.1B | $11.4B | $11.2B | |
| Cash and Short Terms | $1.1B | $882.2M | $787.5M | $595M | $612M | |
| Total Debt | $1.6B | $1.5B | $1.5B | $1.4B | $2.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $419.8M | $901.5M | $874.7M | $1.2B | -$485.6M | |
| Depreciation & Amoritzation | $272M | $281.8M | $269.6M | $288.1M | $332.2M | |
| Stock-Based Compensation | $37.6M | $27.4M | $34M | $46.4M | $18.4M | |
| Change in Accounts Receivable | -$90.5M | -$207.7M | -$306.1M | -$443.8M | $59.1M | |
| Change in Inventories | $119.7M | -$762.6M | -$668.3M | -$164.4M | $308.8M | |
| Cash From Operations | $896.5M | $660.2M | $838.2M | $1.1B | $689.9M | |
| Capital Expenditures | $269.9M | $269.8M | $388.3M | $518.1M | $393.3M | |
| Cash Acquisitions | $26.3M | -$9.5M | -$107.3M | -$31.4M | -$1.3B | |
| Cash From Investing | -$241.7M | -$288.4M | -$496.8M | -$545.7M | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$48M | -$358.5M | -$404.3M | -$457.4M | -$273.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $2.5B | $410.5M | $329.8M | $1.9B | |
| Long-Term Debt Repaid | -$1B | -$2.5B | -$377.5M | -$458.6M | -$513.4M | |
| Repurchase of Common Stock | -$55M | -$135M | -- | -$53M | -$22M | |
| Other Financing Activities | -$24.3M | -$42.2M | -$35.7M | -$32.5M | -$21.7M | |
| Cash From Financing | $22.7M | -$539.5M | -$407M | -$671.7M | $1B | |
| Beginning Cash (CF) | $432.8M | $1.1B | $889.1M | $789.5M | $595.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $677.5M | -$167.7M | -$65.6M | -$114.3M | $85M | |
| Ending Cash (CF) | $1.1B | $889.1M | $789.5M | $595.5M | $612.7M | |
| Levered Free Cash Flow | $626.6M | $390.4M | $449.9M | $585M | $296.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $135.4M | $283.3M | $322.2M | $339M | -$313.6M | |
| Depreciation & Amoritzation | $72.4M | $71.8M | $67.1M | $75.9M | $88.4M | |
| Stock-Based Compensation | $10.8M | $6.3M | $8.6M | $8.9M | -$2.9M | |
| Change in Accounts Receivable | $174.2M | $39.7M | -$3.9M | $37.8M | $161.5M | |
| Change in Inventories | $173.1M | $105.9M | $283.4M | $378.5M | $529.9M | |
| Cash From Operations | $672.4M | $618.7M | $1.1B | $900.4M | $797.9M | |
| Capital Expenditures | $86.8M | $71.1M | $117.8M | $160.4M | $114M | |
| Cash Acquisitions | $33.8M | $8.5M | $5.6M | -$9.2M | $623.4M | |
| Cash From Investing | -$52M | -$73.2M | -$115.9M | -$167M | $531.1M | |
| Dividends Paid (Ex Special Dividend) | -$12M | -$14.9M | -$17.9M | -$21.6M | -$21.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1B | -$636M | -$395.7M | -$748.9M | |
| Long-Term Debt Repaid | -$17.9M | -$1.1B | -$218.7M | -$310.1M | -$511.1M | |
| Repurchase of Common Stock | -- | -$60M | -- | -- | -- | |
| Other Financing Activities | -$6.9M | -$4.6M | -$4M | -$2.5M | -$2.2M | |
| Cash From Financing | -$36.8M | -$161.9M | -$876.6M | -$782.9M | -$1.3B | |
| Beginning Cash (CF) | $511M | $537M | $607M | $680.7M | $642.6M | |
| Foreign Exchange Rate Adjustment | $24.5M | -$31.5M | $41.7M | -$35.7M | -$53.1M | |
| Additions / Reductions | $583.6M | $383.6M | $140.8M | -$49.5M | $23.2M | |
| Ending Cash (CF) | $1.1B | $889.1M | $789.5M | $595.5M | $612.7M | |
| Levered Free Cash Flow | $585.6M | $547.6M | $1B | $740M | $683.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $419.8M | $901.5M | $874.7M | $1.2B | -$485.6M | |
| Depreciation & Amoritzation | $272M | $281.8M | $269.6M | $288.1M | $332.2M | |
| Stock-Based Compensation | $37.6M | $27.4M | $34M | $46.4M | $18.4M | |
| Change in Accounts Receivable | -$90.5M | -$207.7M | -$306.1M | -$443.8M | $59.1M | |
| Change in Inventories | $119.7M | -$762.6M | -$668.3M | -$164.4M | $308.8M | |
| Cash From Operations | $896.5M | $660.2M | $838.2M | $1.1B | $689.9M | |
| Capital Expenditures | $269.9M | $269.8M | $388.3M | $518.1M | $393.3M | |
| Cash Acquisitions | $26.3M | -$9.5M | -$107.3M | -$31.4M | -$1.3B | |
| Cash From Investing | -$241.7M | -$288.4M | -$496.8M | -$545.7M | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$48M | -$358.5M | -$404.3M | -$457.4M | -$273.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $2.5B | $410.5M | $329.8M | $1.9B | |
| Long-Term Debt Repaid | -$1B | -$2.5B | -$377.5M | -$458.6M | -$513.4M | |
| Repurchase of Common Stock | -$55M | -- | -- | -- | -- | |
| Other Financing Activities | -$24.3M | -$42.2M | -$35.7M | -$32.5M | -$21.7M | |
| Cash From Financing | $22.7M | -$539.5M | -$407M | -$671.7M | $1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $677.5M | -$167.7M | -$65.6M | -$114.3M | $85M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $626.6M | $390.4M | $449.9M | $585M | $296.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $901.5M | $874.7M | $1.2B | -$485.6M | -- | |
| Depreciation & Amoritzation | $281.8M | $269.6M | $288.1M | $332.2M | -- | |
| Stock-Based Compensation | $27.4M | $34M | $46.4M | $18.4M | -- | |
| Change in Accounts Receivable | -$207.7M | -$306.1M | -$443.8M | $59.1M | -- | |
| Change in Inventories | -$762.6M | -$668.3M | -$164.4M | $308.8M | -- | |
| Cash From Operations | $660.2M | $838.2M | $1.1B | $689.9M | -- | |
| Capital Expenditures | $269.8M | $388.3M | $518.1M | $393.3M | -- | |
| Cash Acquisitions | -$9.5M | -$107.3M | -$31.4M | -$1.3B | -- | |
| Cash From Investing | -$288.4M | -$496.8M | -$545.7M | -$1.7B | -- | |
| Dividends Paid (Ex Special Dividend) | -$358.5M | -$404.3M | -$457.4M | -$273.1M | -- | |
| Special Dividend Paid | $4M | $4.5M | $5M | $2.5M | -- | |
| Long-Term Debt Issued | $2.5B | $410.5M | $329.8M | $1.9B | -- | |
| Long-Term Debt Repaid | -$2.5B | -$377.5M | -$458.6M | -$513.4M | -- | |
| Repurchase of Common Stock | -$135M | -- | -- | -- | -- | |
| Other Financing Activities | -$42.2M | -$35.7M | -$32.5M | -$21.7M | -- | |
| Cash From Financing | -$539.5M | -$407M | -$671.7M | $1B | -- | |
| Beginning Cash (CF) | $2.6B | $2.7B | $2.5B | $4.4B | -- | |
| Foreign Exchange Rate Adjustment | -$62.3M | -$34M | -$79.7M | -$67.8M | -- | |
| Additions / Reductions | -$167.7M | -$65.6M | -$114.3M | $85M | -- | |
| Ending Cash (CF) | $2.4B | $2.6B | $2.3B | $4.4B | -- | |
| Levered Free Cash Flow | $390.4M | $449.9M | $585M | $296.6M | -- | |
Get AGCO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AGCO
Sector
P/E ratio
43.40x
17.55x
PEG ratio
0.53x
0.28x
P/B ratio
1.86x
1.69x
Price / LTM sales
0.60x
0.89x
Growth Metrics
AGCO
Sector
Revenue growth
-24.03%
3.05%
Earnings growth
-89.31%
6.36%
Revenue (5-year growth)
5.22%
4.43%
Earnings forecast
$1.05
$0.36
Profitability
AGCO
Sector
Profitability FY 2024
$2.9B
$409.9M
Return on invested capital
-5.56%
5.7%
Return on assets
-3.36%
3.56%
Return on equity
-9.44%
8.62%
Earnings Date
Last Earnings Date
Feb
6
Next Earnings Date
May
2
Estimated Next Earnings Date
May
8
Balance Sheet
AGCO
Sector
Total cash
$612M
$163.9M
Short term investments
--
$42.1M
Total assets
$11.2B
$1.9B
Long term debt
$2.6B
$272.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
